In Vitro Translation

mRNA display is an in vitro selection and evolution technique for functional peptides and proteins. In mRNA display, in vitro translation enables the production of proteins using cellular machinery in a cell-free system. These proteins can then undergo subsequent screening for desired properties. CD BioSciences offers mRNA display-based drug discovery services that encompass the entire early drug discovery process.

Peptide Selection Using mRNA Display - CD BioSciencesFig 1. General scheme for peptide selection by mRNA display.

In Vitro Translation in mRNA Display

In vitro translation, also termed in vitro protein expression, cell-free protein synthesis, or cell-free translation, allows rapid production of small functional protein quantities. Cell-free protein synthesis systems mimic cellular transcription and translation processes in a controlled extracellular environment, enabling detailed exploration of individual components and reaction networks.

Cell-free and in vivo protein synthesis methods.Fig 2. A comparison of cell-free and in vivo protein synthesis methods. (Gregorio, et al., 2019)

With the rapid advancement of cell-free protein synthesis (CFPS), a variety of CFPS systems have emerged. One category is the extract-based systems, which can be subcategorized into high-utilization cell types and low-utilization cell types based on the source of the cell extract. Another category is the PURE system (Protein Synthesis Using Recombinant Elements), developed by Shimizu et al., which synthesizes proteins using recombinant elements in a cell-free transcription-translation system.

Translation Systems Description Advantages Disadvantages
Rabbit Reticulocyte Lysate Derived from rabbit reticulocytes, this system is rich in ribosomes and translation initiation factors.
  • Capable of post-translational modifications.
  • Enables the expression of membrane proteins and toxic proteins.
  • Low protein yield.
  • Time-consuming.
Wheat Germ Extract Extracted from wheat germ, it's particularly effective for plant-derived proteins.
  • Easy to culture.
  • Suitable for studying eukaryotic transcription and translation mechanisms.
  • Low protein yield.
  • Insufficient post-translational modifications.
E. coli Extract E. coli cell-free systems consist of a crude extract that is rich in endogenous mRNA.
  • Rapid growth rate.
  • Easy to culture.
  • High yield.
  • Cost-effective.
  • Lacks post-translational modifications.
Insect Cell-Free Systems Obtained from insect cells, these systems provide translation efficiencies similar to mammalian cells.
  • Capable of post-translational modifications.
  • Enables the expression of membrane proteins and toxic proteins.
  • Low protein yield
  • Need more extracts
Mammalian Cell-Free Systems Derived from mammalian cells, offering translation and post-translational modifications akin to those occurring in vivo.
  • Capable of post-translational modifications.
  • Enables the expression of membrane proteins and toxic proteins.
  • Low protein yield
PURE (protein synthesis using recombinant elements) PURE system utilizes individually purified components in place of cell extract.
  • Defined system
  • Reduced contaminants
  • Freedom from cellular regulation
  • Simplified troubleshooting
  • Expression efficiency
  • Limited post-translational modifications
  • Limited scale

Our Services

In mRNA display, commonly employed translation systems include the rabbit reticulocyte lysate and the PURE system. CD BioSciences utilizes the PURE system for in vitro translation processes. With the PURE system, all components are well-defined, devoid of nucleases and proteases, allowing for the optimization of each element's concentration to achieve maximal protein expression. These reorganization elements include the following.

CD BioSciences' in vitro translation process can rapidly generate substantial amounts of protein for further characterization, saving valuable laboratory time and making it ideal for high-throughput technologies.

  • Initiation factors (IF1, IF2, IF3).
  • Elongation factors (EF-Tu, EF Ts, EF-G), the
  • Release factors (RF1, RF2, RF3).
  • Ribosome recycling factor
  • 20 aminoacyl-tRNA synthetases
  • Methionyl-tRNA formyltransferase
  • Pyrophosphatase.

These recombinant components are mixed with ribosomes, tRNA, essential NTPs and amino acids isolated from E. coli, ATP, and recombinant T7 RNA polymerase to synthesize proteins using mRNA-puromycin conjugates.

General workflow for preparation of cell-free extract. - CD BioSciences

Contact Us

CD BioSciences is committed to providing expert guidance and support throughout the drug development process. We work closely with our clients to develop tailored strategies that maximize the potential of their drug development programs. To learn more about how we can support your drug development efforts with our mRNA display services, please contact us.

References

  1. Gregorio, N.E., et al. A user's guide to cell-free protein synthesis. Methods and Protocols. 2019, 2(1): 24.
For Research Use Only. Not For Clinical Use.

Related Services

Our Company Information
  • Tel:
  • Email:
Copyright © CD BioSciences. All Rights Reserved.
Top